<DOC>
	<DOC>NCT01387035</DOC>
	<brief_summary>The purposes of this study are (I), to evaluate various screening methods for their ability to predict and to confirm Pulmonary Hypertension (PH) in scleroderma patients, and (II) to evaluate the incidence of PH (i.e. the number of new cases per year) in scleroderma patients.</brief_summary>
	<brief_title>Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<criteria>consent form men and women&gt; 18 years fulfill the current definition of a collagen vascular disease according to the actual guidelines of the American College of Rheumatology (ACR) all contraindications for exercise testing significant restriction of the left ventricle, unstable coronary artery disease and myocardial infarction in the last 6 months patients with other lung diseases (as the pulmonary infestations as part of systemic disease) or related musculoskeletal disorders influencing baseline exercise capacity pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>